TP53 and lung cancer: First, we explored the presence of other somatic TP53 functional/pathogenic variants in lung cancer specimens from rs78378222[C] carriers by NGS analyses, which allowed us to identify that all four variant-positive tumors with sample availability had additional pathogenic or likely pathogenic variants in the TP53 coding regions.